Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients
Open Access
- 24 July 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (14) , 2199-2207
- https://doi.org/10.1001/archinte.160.14.2199
Abstract
EPIDEMIOLOGICAL data demonstrate that perioperative and postoperative venous thrombosis are common in high-risk patients undergoing surgery.1-5 In the absence of thromboprophylaxis, this disorder occurs in 40% to 60% of patients receiving hip implants.5,6 Prophylactic recommendations against venous thromboembolism in patients undergoing hip arthroplasty include warfarin sodium and subcutaneous low-molecular-weight heparin therapy.5,6This publication has 23 references indexed in Scilit:
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Subcutaneous Low-Molecular Weight Heparin or Oral Anticoagulants for the Prevention of Deep-Vein Thrombosis in Elective Hip and Knee Replacement?Thrombosis and Haemostasis, 1995
- Efficacy and Safety of Enoxaparin to Prevent Deep Venous Thrombosis after Hip Replacement SurgeryAnnals of Internal Medicine, 1994
- Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.Journal of Bone and Joint Surgery, 1994
- A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee ImplantationNew England Journal of Medicine, 1993
- Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparinJournal of Vascular Surgery, 1993
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ, 1991
- Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery. A placebo controlled studyThe Journal of Bone and Joint Surgery. British volume, 1991
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986